PROMISE-1: Migraine nipped in the bud with eptinezumab drip
21 Dec 2020
byJairia Dela Cruz
Intravenous eptinezumab has demonstrated early and sustained migraine-preventive effects with a favourable safety profile in adult patients with episodic migraine, according to the 1-year results of the phase III PROMISE-1* study.
PROMISE-1: Migraine nipped in the bud with eptinezumab drip
21 Dec 2020
